LOGO
LOGO

Wockhardt Gets US FDA Approval For Midazolam Injection, Launches It In US Market

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Wockhardt said that the company received approval from the United States Food & Drug Administration for marketing the preservative-free version injections containing 1mg/ml and 5 mg /ml Midazolam in US market and launched it. Earlier, the company received the US FDA approval for the injection containing preservatives.

Midazolam is the generic name for the brand Versed. It is used in treatment of acute insomnia and anxiety and has a total market of $56 million as per IMS data.

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

Latest Updates on COVID-19